摘要

<正>Severe acute respiratory syndrome coronavirus 2(SARS-Co V-2)has placed a heavy burden on the global healthcare system, especially in developing and underdeveloped countries where professionals and specialized laboratories are scarce. And due to the increased demand for large-scale detection and the shortage of animal models for vaccines and antiviral drugs under the coronavirus disease 2019(COVID-19) pandemic,